Literature DB >> 7410839

Regulation of the immune response. II. Characterization of the cell population(s) involved in the Fc fragment-induced adjuvant effect.

E L Morgan, M L Thoman, S M Walker, W O Weigle.   

Abstract

Fc fragments derived from human and murine Ig have been shown to possess adjuvant properties. The spleen cell population(s) affected by the Fc fragments is the T lymphocyte. That Fc fragments do not act directly on the B lymphocyte was shown by the fact that in a system where T cell help was substituted for by TRF and using TI antigens, no adjuvant effect was observed. The adjuvant signal provided by the Fc fragments is needed early in the culture period, because it was reduced by approximately 50% when delayed by 24 hr. When the addition of Fc was delayed by 72 hr, the antibody response was not significantly increased over the culture that received antigen only.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7410839

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Isolation and identification of a biologically active peptide derived from the CH3 domain of human IgG1.

Authors:  E L Morgan; T E Hugli; W O Weigle
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

2.  Potentiation of specific human in vitro immune responses by the Fc portion of human immunoglobulin.

Authors:  E L Morgan; W O Weigle
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

3.  IgG aggregates of different sizes stimulate or suppress Ig secretion by human lymphocytes in vitro.

Authors:  C Wiesenhutter; D W Knutson; D S Musgrave; R F Ashman
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

4.  Enhancement of T lymphocyte functions by Fc fragments of immunoglobulins. I. Augmentation of allogeneic mixed lymphocyte culture reactions requires I-A- or I-B-subregion differences between effector and stimulator cell populations.

Authors:  E L Morgan; M L Thoman; W O Weigle
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

5.  Synthetic Fc peptide-mediated regulation of the immune response. I. Characterization of the immunomodulating properties of a synthetic 23-amino acid peptide derived from the sequence of the CH3 domain of human IgG1.

Authors:  E L Morgan; J E Shields; C S Campbell; R L Barton; G A Koppel; W O Weigle
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.